Evidence map›Paper›PMID 41378172›Full record

ArticleFrontiers in sports and active living2025

Menstrual cycle or hormonal contraceptive related symptoms in elite female athletes from retrospective self-questionnaires and daily monitoring: impact on well-being and objective performance metrics.

Nolwenn Badier, Marine Dupuit, Tom Chassard, Kilian Barlier, Alice Lafitte, Guillaume Saulière, Lidia Delrieu, Jean-François Toussaint, Juliana Antero

Abstract read
In one paragraph

Article in Frontiers in sports and active living, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nolwenn Badier *UMR 7329-Institute for Research in Medicine and Epidemiology of Sport (IRMES), Université Paris Cité, National Institute of Sport, Expertise and Performance (INSEP), Paris, France.
Marine Dupuit *UMR 7329-Institute for Research in Medicine and Epidemiology of Sport (IRMES), Université Paris Cité, National Institute of Sport, Expertise and Performance (INSEP), Paris, France.
Tom ChassardUMR 7329-Institute for Research in Medicine and Epidemiology of Sport (IRMES), Université Paris Cité, National Institute of Sport, Expertise and Performance (INSEP), Paris, France.
Kilian BarlierUMR 7329-Institute for Research in Medicine and Epidemiology of Sport (IRMES), Université Paris Cité, National Institute of Sport, Expertise and Performance (INSEP), Paris, France.
Alice LafitteUMR 7329-Institute for Research in Medicine and Epidemiology of Sport (IRMES), Université Paris Cité, National Institute of Sport, Expertise and Performance (INSEP), Paris, France.
Guillaume SaulièreUMR 7329-Institute for Research in Medicine and Epidemiology of Sport (IRMES), Université Paris Cité, National Institute of Sport, Expertise and Performance (INSEP), Paris, France.
Lidia DelrieuUMR 7329-Institute for Research in Medicine and Epidemiology of Sport (IRMES), Université Paris Cité, National Institute of Sport, Expertise and Performance (INSEP), Paris, France.
Jean-François ToussaintUMR 7329-Institute for Research in Medicine and Epidemiology of Sport (IRMES), Université Paris Cité, National Institute of Sport, Expertise and Performance (INSEP), Paris, France.
Juliana AnteroUMR 7329-Institute for Research in Medicine and Epidemiology of Sport (IRMES), Université Paris Cité, National Institute of Sport, Expertise and Performance (INSEP), Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Negative menstrual cycle-related symptoms have been shown to perceptually impact well-being, as well as training and competition performance, yet they are rarely daily monitored over extended periods. The aim is to compare menstrual cycle (MC) and hormonal contraception (HC) related symptoms reported through retrospective and daily questionnaires in elite female athletes and to assess their association with well-being and performance metrics. Methods: Data were collected from 108 elite female athletes across seven sports over 554 full cycles. Participants completed a retrospective questionnaire on regular symptoms and provided daily prospective entries for 6 months ( Results: Athletes reported more symptoms retrospectively than in daily questionnaires. Mood swings, tiredness, and pelvic pain were the most common retrospective symptoms, while bloating, tiredness, and pelvic pain were most frequent in daily entries. MC athletes reported more symptoms than HC users in both methods. According to the daily follow-up, symptoms were more frequent during menstruation and the prebleeding phase for MC athletes and the break phase for HC users. A significant negative correlation was observed between symptoms and well-being indicators. In football players, high-speed running distance significantly declined on symptomatic days. Conclusion: Retrospective questionnaires shows a greater symptom prevalence than daily monitoring. Symptoms, more frequent during bleeding phases, negatively impacted athletes' well-being and also high-speed running performance for football players. These findings highlight the importance of individualized monitoring and tailored interventions to optimize athlete health, well-being, and performance.

Indexed as

athletesathletic performancemenstrual cyclemenstrual symptomsmonitoringsurvey and questionnaire

Identifiers

PMID41378172
PMCPMC12685902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.